普雷尼索隆补充剂在早期精神分裂症:一个随机,双盲,安慰剂控制的试点研究
Gunnhild E Hoprekstad1,2,3, Erik Johnsen1,2,3, Christoffer Bartz-Johannessen1,3
1Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Brain, behavior, & immunity - health
|July 29, 2025
概括
添加普雷迪尼索隆显示了减少精神分裂症患者精神病症状的趋势. 需要进一步的研究来证实这些发现,并探索潜在的作用机制.
科学领域:
- 精神病学是一个精神病学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的精神分裂症治疗方法在有效性和耐受性方面存在局限性.
- 异常免疫系统活动与精神分裂症有关,但治疗的转化仍在等待.
- 强大的抗炎药物,如普得尼索隆,可能提供一种新的治疗方法.
研究的目的:
- 调查普得尼索隆作为精神分裂症的补充疗法的疗效.
- 建立在精神分裂症治疗中减轻炎症的概念验证.
主要方法:
- 这是一项双盲多中心试点研究,涉及12名精神分裂症患者,接受稳定的抗精神病治疗方案.
- 患者随机分配,接受普雷迪尼索隆 (40毫克/天,逐渐减少6周) 或安慰剂.
- 主要结局是6周后阳性和阴性综合征量表 (PANSS) 总得分的变化.
主要成果:
- 与安慰剂相比,在普得尼索隆组观察到更大程度地减少精神病症状的趋势 (PANSS总得分差异:15.4,p=0.101).
- 在普丁尼索隆组的PANSS总得分中发现了统计学上显著的改善 (差异:12.5分,p=0.021).
- 在6周的治疗期间,普雷迪尼索隆被发现是安全的,并且耐受良好.
结论:
- 添加普雷尼索隆可能有助于减少精神分裂症中精神病症状.
- 需要进行更大规模的研究来证实这些初步发现并阐明作用机制.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
01:28Psychosis and Antipsychotic Drugs: Overview
458
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
458
01:28Drug Therapy
100
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
100
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397
01:26COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314